A detailed history of Black Rock Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Black Rock Inc. holds 14,144,988 shares of BIIB stock, worth $3.28 Billion. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,144,988
Previous 14,246,658 0.71%
Holding current value
$3.28 Billion
Previous $3.69 Billion 17.27%
% of portfolio
0.07%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$212.02 - $267.71 $21.6 Million - $27.2 Million
-101,670 Reduced 0.71%
14,144,988 $3.05 Billion
Q4 2023

Feb 13, 2024

BUY
$222.59 - $267.94 $60.6 Million - $72.9 Million
272,071 Added 1.95%
14,246,658 $3.69 Billion
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $23.2 Million - $26.1 Million
-91,407 Reduced 0.65%
13,974,587 $3.59 Billion
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $22 Million - $25.4 Million
79,773 Added 0.57%
14,065,994 $4.01 Billion
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $70.4 Million - $80.2 Million
-274,392 Reduced 1.92%
13,986,221 $3.89 Billion
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $104 Million - $127 Million
413,887 Added 2.99%
14,260,613 $3.95 Billion
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $120 Million - $166 Million
-616,733 Reduced 4.26%
13,846,726 $3.7 Billion
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $64.2 Million - $76.4 Million
342,362 Added 2.42%
14,463,459 $2.95 Billion
Q1 2022

May 12, 2022

BUY
$193.77 - $244.14 $77.3 Million - $97.4 Million
399,143 Added 2.91%
14,121,097 $2.97 Billion
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $39 Million - $50.2 Million
-174,299 Reduced 1.25%
13,721,954 $3.29 Billion
Q3 2021

Nov 09, 2021

BUY
$282.99 - $369.05 $195 Million - $255 Million
689,662 Added 5.22%
13,896,253 $3.93 Billion
Q2 2021

Aug 11, 2021

BUY
$259.0 - $414.71 $3.42 Billion - $5.48 Billion
13,206,591 New
13,206,591 $4.57 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $33.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.